mAnaging siCkle CELl disease through incReased AdopTion of hydroxyurEa in Nigeria (ACCELERATE)
mAnaging siCkle CELl disease through incReased AdopTion of hydroxyurEa in Nigeria (ACCELERATE)
批准号:
10638598
负责人:
Obiageli Eunice Nnodu
金额:
$70.84万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2023
资助国家:
美国
项目状态:
未结题
起止时间:
2023-08-15 至 2028-07-31
关键词:
AddressAdoptedAdoptionAfricaAfricanAlgorithmsBirthBlood TransfusionCaringCephalicClinicalClinical TrialsConsultationsCounselingCountryDiseaseDisease ManagementEducationEducational workshopEffectivenessEnsureExploration, Preparation, Implementation, and SustainmentFeedbackFocus GroupsFundingGhanaGovernmentGuidelinesHealthHealth PersonnelHealth educationHealthcareHematologistHemoglobinopathiesHydration statusInfectionInfrastructureInterventionInterviewIonsKnowledgeMediatorMedicineMethodsNeonatal ScreeningNigeriaNigerianNursesPatient-Focused OutcomesPatientsPersonsPhasePhysiciansPoliciesPreparationProphylactic treatmentProtocols documentationProviderPublic HealthPublished CommentRandomizedResearch DesignResource-limited settingSickle Cell AnemiaSpecialistStructureSystemTimeTrainingUnited States National Institutes of Healthadverse outcomeclinical research siteclinical trainingcontrol trialdosageeffectiveness evaluationevidence basefollow-uphealth care service organizationhealth traininghydroxyureahypertension controlimplementation barriersimplementation designimplementation facilitationimplementation fidelityimplementation processimplementation strategyimprovedlow and middle-income countriesmortalitynutritionpatient orientedpatient screeningprimary outcomeprovider adoptionprovider-level barriersscale upscreeningsecondary outcomesystematic reviewtailored health caretool
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Project Summary/Abstract
Large knowledge gaps remain regarding strategies to promote the adoption of hydroxyurea (HU), particularly in
sub-Saharan African countries including Nigeria, where more than 75% of annual sickle cell anemia births occur.
The vast majority of people with SCD in Africa do not receive evidenced-based health care (e.g., newborn
screening, health education, prophylaxis for infection, optimal nutrition and hydration, blood transfusion,
transcranial Doppler screening, and HU therapy), despite its effectiveness in reducing SCD-related adverse
outcomes and mortality. The use of HU in SSA is <1% among SCD patients. Our preliminary findings indicate
that provider-level barriers are significant and must be addressed to improve HU adoption. To address HU
adoption we will use the NIH-funded study (e.g., Realizing Effectiveness Across Continents with Hydroxyurea
(REACH) Clinical Trial (NCT01966731)) that developed an evidence-informed, clinical, practical, and easy-to-
follow algorithm to 1) Screen patients for sickle cell disease (SCD), 2) Initiate HU treatment, and 3) Maintain HU
dosage over time (SIM) for the improved management of SCD as our intervention. The Nigerian government
released guidelines supporting the SIM intervention for HU adoption for improved SCD management, and HU is
on the list of essential medicines for Nigeria. Our implementation strategy for improving SCD management in
Nigeria uses a practical and replicable evidence-based task-sharing strategy, TAsk-Strengthening Strategy for
Hemoglobinopathies (TASSH), adopted from our TAsk-Strengthening Strategy for Hypertension control
(TASSH) trials in Ghana and Nigeria containing the essential components of i) Training healthcare
workers/providers to be more patient-centered in clinical consultations, ii) Clinical reminders, and iii) Practice
facilitation (TCP) known as (TASSH TCP) for SCD management. Using a sequential exploratory mixed-methods
study design, we will conduct this study using the Exploration, Preparation, Implementation, and Sustainment
(EPIS) framework in four sequential phases to assess the effectiveness of SIM adoption by providers in the
context of the TASSH TCP implementation strategy in Nigeria.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Sickle Pan African Research Consortium Nigeria (SPARC-NEt)
-
批准号:10634631
-
项目类别:
-
资助金额:$25.19万
-
财政年份:2021
-
负责人:Obiageli Eunice Nnodu
-
依托单位:
Sickle Pan African Research Consortium NigEria (SPARC-NEt)
-
批准号:10414923
-
项目类别:
-
资助金额:$25.26万
-
财政年份:2021
-
负责人:Obiageli Eunice Nnodu
-
依托单位:
Sickle Pan African Research Consortium NigEria (SPARC-NEt)
-
批准号:10186372
-
项目类别:
-
资助金额:$22.89万
-
财政年份:2021
-
负责人:Obiageli Eunice Nnodu
-
依托单位:
海外基金